Literature DB >> 24338203

Effects of sesamin on the biosynthesis of chondroitin sulfate proteoglycans in human articular chondrocytes in primary culture.

Peraphan Pothacharoen1, Sumet Najarus, Jongkolnee Settakorn, Shuji Mizumoto, Kazuyuki Sugahara, Prachya Kongtawelert.   

Abstract

Osteoarthritis (OA) is a degenerative joint disease that progressively causes a loss of joint functions and the impaired quality of life. The most significant event in OA is a high degree of degradation of articular cartilage accompanied by the loss of chondroitin sulfate-proteoglycans (CS-PGs). Recently, the chondroprotective effects of sesamin, the naturally occurring substance found in sesame seeds, have been proved in a rat model of papain-induced osteoarthritis. We hypothesized that sesamin may be associated with possible promotion of the biosynthesis of CS-PGs in human articular chondrocytes. The aim of the study was to investigate the effects of sesamin on the major CS-PG biosynthesis in primary human chondrocyte. The effects of sesamin on the gene expression of the PG core and the CS biosynthetic enzymes as well as on the secretion of glycosaminoglycans (GAGs) in monolayer and pellet culture systems of articular chondrocytes. Sesamin significantly increased the GAGs content both in culture medium and pellet matrix. Real-time-quantitative PCR showed that sesamin promoted the expression of the genes encoding the core protein (ACAN) of the major CS-PG aggrecan and the biosynthetic enzymes (XYLT1, XYLT2, CHSY1 and CHPF) required for the synthesis of CS-GAG side chains. Safranin-O staining of sesamin treated chondrocyte pellet section confirmed the high degree of GAG accumulation. These results were correlated with an increased level of secreted GAGs in the media of cultured articular chondrocytes in both culture systems. Thus, sesamin would provide a potential therapeutic strategy for treating OA patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24338203     DOI: 10.1007/s10719-013-9514-6

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  40 in total

1.  Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis.

Authors:  David J Hunter; Barton Wise
Journal:  Evid Based Med       Date:  2007-06

2.  Two-Step versus One-Step RNA-to-CT 2-Step and One-Step RNA-to-CT 1-Step: validity, sensitivity, and efficiency.

Authors:  Nasser Al-Shanti; Amarjit Saini; Claire E Stewart
Journal:  J Biomol Tech       Date:  2009-07

Review 3.  The molecular diversity of glycosaminoglycans shapes animal development.

Authors:  Hannes E Bülow; Oliver Hobert
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

Review 4.  Chondroprotective drugs in degenerative joint diseases.

Authors:  G Verbruggen
Journal:  Rheumatology (Oxford)       Date:  2005-11-08       Impact factor: 7.580

Review 5.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

6.  Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles.

Authors:  Henry C Y Chung; Ruby C Y Lin; Grant J Logan; Ian E Alexander; Perminder S Sachdev; Kuldip S Sidhu
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

7.  Chondroprotective and anti-inflammatory effects of sesamin.

Authors:  Thanyaluck Phitak; Peraphan Pothacharoen; Jongkolnee Settakorn; Wilart Poompimol; Bruce Caterson; Prachya Kongtawelert
Journal:  Phytochemistry       Date:  2012-06-14       Impact factor: 4.072

Review 8.  Synthesis and sorting of proteoglycans.

Authors:  K Prydz; K T Dalen
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

9.  Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group.

Authors:  J P Pelletier; M Yaron; B Haraoui; P Cohen; M A Nahir; D Choquette; I Wigler; I A Rosner; A D Beaulieu
Journal:  Arthritis Rheum       Date:  2000-10

10.  Influence of renal function on the pharmacokinetics of diacerein after a single oral dose.

Authors:  P Debord; K Louchahi; M Tod; A Cournot; G Perret; O Petitjean
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

View more
  2 in total

1.  Targeting Human Osteoarthritic Chondrocytes with Ligand Directed Bacteriophage-Based Particles.

Authors:  Aitthiphon Chongchai; Sajee Waramit; Tunchanok Wongwichai; Jirawan Kampangtip; Thanyaluck Phitak; Prachya Kongtawelert; Amin Hajitou; Keittisak Suwan; Peraphan Pothacharoen
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

2.  Effects of sesamin on chondroitin sulfate proteoglycan synthesis induced by interleukin-1beta in human chondrocytes.

Authors:  Warunee Srisuthtayanont; Dumnoensun Pruksakorn; Prachya Kongtawelert; Peraphan Pothacharoen
Journal:  BMC Complement Altern Med       Date:  2017-05-31       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.